American Heart Journal
Volume 143, Issue 5 , Pages 777-789 , May 2002

Critical pathways for management of patients with acute coronary syndromes: An assessment by the National Heart Attack Alert Program

  • National Heart Attack Alert Program (NHAAP) Coordinating Committee Critical Pathways Writing Group

Received 11 April 2001 ,Accepted 24 September 2001.

References 

  1. Velasco FT, Ko W, Rosengart T, et al.  Cost containment in cardiac surgery: results with a critical pathway for coronary bypass surgery at the New York Hospital-Cornell Medical Center. Best Pract Benchmarking Healthc. 1996;1:21–28
  2. Riegel B, Gates DM, Gocka I, et al.  Effectiveness of a program of early hospital discharge of cardiac surgery patients. J Cardiovasc Nurs. 1996;11:63–75 [published erratum appears in J Cardiovasc Nurs 1997;11:1]
  3. Califf RM, Bartrug B, Rogers MC, et al.  Developing a rational system to contain costs on the cardiac care unit. In: 2nd ed.  Califf RM,  Mark DB,  Wagner GS editor. Acute coronary care. St Louis: Mosby; 1995;p. 895–912
  4. Pearson SD, Goulart-Fisher D, Lee TH. Critical pathways as a strategy for improving care. Ann Intern Med. 1995;123:941–948
  5. Eagle KA, Lee TH, Brennan TA, et al.  Task Force 2: guideline implementation. J Am Coll Cardiol. 1997;29:1141–1148
  6. Nichol G, Walls R, Goldman L, et al.  A critical pathway for management of patients with acute chest pain at low risk for myocardial ischemia. Recommendations and potential impact. Ann Intern Med. 1997;127:996–1005
  7. Ritchie JL, Forrester JS, Frye WB. 28th Bethesda conference: practice guidelines and the quality of care. J Am Coll Cardiol. 1997;29:1125–1179
  8. National Heart Attack Alert Program Coordinating Committee—60 Minutes to Treatment Working Group . Emergency department: rapid identification and treatment of patients with acute myocardial infarction. Ann Emerg Med. 1994;23:311–329
  9. Cannon CP, Antman EM, Walls R, et al.  Time as an adjunctive agent to thrombolytic therapy. J Thromb Thrombol. 1994;1:27–34
  10. National Heart Attack Alert Program Coordinating Committee Access to Care Subcommittee . Staffing and equipping emergency medical services systems: rapid identification and treatment of acute myocardial infarction. Am J Emerg Med. 1995;13:58–65
  11. National Heart Attack Alert Program Coordinating Committee Access to Care Subcommittee . Emergency medical dispatching: rapid identification and treatment of acute myocardial infarction. Am J Emerg Med. 1995;13:67–73
  12. National Heart Attack Alert Program Coordinating Committee Access to Care Subcommittee . 9-1-1: rapid identification and treatment of acute myocardial infarction. Am J Emerg Med. 1995;13:188–195
  13. Dracup K, Alonzo AA, Atkins JM, et al.  The physician's role in minimizing prehospital delay in patients at high risk for acute myocardial infarction: recommendations from the National Heart Attack Alert Program. Ann Intern Med. 1997;126:645–651
  14. National Heart Attack Alert Program Coordinating Committee Working Group on Educational Strategies to Prevent Prehospital Delay in Patients at High Risk for Acute Myocardial Infarction . Educational strategies to prevent prehospital delay in patients at high risk for acute myocardial: a report by the National Heart Attack Alert Program. J Thromb Thrombol. 1998;6:47–61
  15. Zalenski RJ, Selker HP, Cannon CP, et al.  National Heart Attack Alert Program position paper: chest pain centers and programs for the evaluation of acute cardiac ischemia. Ann Emerg Med. 2000;35:462–471
  16. Every NR, Hochman J, Becker R, et al.  Critical pathways: a review. Committee on Acute Cardiac Care, Council on Clinical Cardiology, American Heart Association. Circulation. 2000;101:461–465
  17. Roark MK. Critical pathways. J Healthc Resour Manag. 1997;15:12–15
  18. Poirrier GP, Oberleitner MG. Introduction to Clinical Pathways.. In: Clinical Pathways in Nursing. A Guide to Managing from Hospital to Home. Springhouse (PA): Springhouse Corporation; 1999;p. 2–8
  19. Zalenski RJ, Rydman RJ, Ting S, et al.  A national survey of “chest pain centers” in the United States: structure and characteristics of host emergency departments and hospitals. Am J Cardiol. 1998;81:1305–1309
  20. Bahr RD. Growth in chest pain emergency departments throughout the United States: a cardiologist's spin on solving the heart attack problem. Coron Artery Dis. 1995;6:827–838
  21. Selker HP, Zalenski RJ, Antman EM, et al.  An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: a report from a National Heart Attack Alert Program working group. Ann Emerg Med. 1997;29:13–87
  22. Lau J, Ioannidis J, Balk E, et al.  Evaluation of technologies for identifying acute cardiac ischemia in emergency departments: evidence report/technology assessment number 26. Rockville (Md): Agency for Healthcare Research and Quality; May 2001; (Prepared by the New England Medical Center Evidence-based Practice Center under Contract No. 290-97-0019) AHRQ Publication No. 01-E006
  23. Pilote L, Califf RM, Sapp S, et al.  Regional variation across the United States in the management of acute myocardial infarction. N Engl J Med. 1995;333:565–572
  24. Pell ACH, Miller HC, Robertson CE, et al.  Effect of “fast track” admission for acute myocardial infarction on delay to thrombolysis. BMJ. 1992;304:83–87
  25. Lambrew CT. Emergency department triage of patients with nontraumatic chest pain. ACC Curr J Rev. 1995;4:61–62
  26. Cannon CP, Johnson EB, Cermignani M, et al.  Emergency department thrombolysis critical pathway reduces door-to-drug times in acute myocardial infarction. Clin Cardiol. 1999;22:17–22
  27. Cannon CP, Gibson CM, Lambrew CT, et al.  Longer thrombolysis door-to-needle times are associated with increased mortality in acute myocardial infarction: an analysis of 85,589 patients in the National Registry of Myocardial Infarction 2+3. J Am Coll Cardiol. 2000;35:376; [abstract]
  28. Cannon CP, Gibson CM, Lambrew CT, et al.  Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA. 2000;283:2941–2947
  29. Caputo RP, Ho KK, Stoler RC, et al.  Effect of continuous quality improvement analysis on the delivery of primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol. 1997;79:1159–1164
  30. Ward MR, Lo ST, Herity NA, et al.  Effect of audit on door-to-door inflation times in primary angioplasty/stenting for acute myocardial infarction. Am J Cardiol. 2001;87:336–338
  31. Steering Committee of the Physicians' Health Study Research Group . Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med. 1989;321:129–135
  32. Willard JE, Lange RA, Hillis LD. The use of aspirin in ischemic heart disease. N Engl J Med. 1992;327:175–181
  33. Lewis HD, Davis JW, Archibald DG, et al.  Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. N Engl J Med. 1983;309:396–403
  34. Cairns JA, Gent M, Singer J, et al.  Aspirin, sulfinpyrazone, or both in unstable angina. N Engl J Med. 1985;313:1369–1375
  35. Theroux P, Ouimet H, McCans J, et al.  Aspirin, heparin or both to treat unstable angina. N Engl J Med. 1988;319:1105–1111
  36. ISIS Second International Study of Infarct Survival Collaborative Group . Randomized trial of intravenous steptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;2:349–360
  37. RISC Group . Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet. 1990;336:827–830
  38. Roux S, Christeller S, Ludin E. Effects of aspirin on coronary reocclusion and recurrent ischemia after thrombolysis: a meta-analysis. J Am Coll Cardiol. 1992;19:671–677
  39. Klimt CR, Knatterud GL, Stamler J, et al.  Persantine-Aspirin Reinfarction Study, II: secondary coronary prevention with Persantine and aspirin. J Am Coll Cardiol. 1986;7:251–269
  40. Antiplatelet Trialist Collaboration . Collaborative overview of randomised trials of antiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 1994;308:81–106
  41. Rogers WJ, Bowlby LJ, Chandra NC, et al.  Treatment of myocardial infarction in the United States (1990 to 1993): observations from the National Registry of Myocardial Infarction. Circulation. 1994;90:2103–2114
  42. Ellerbeck EF, Jencks SF, Radford MJ, et al.  Quality of care for medicare patients with acute myocardial infarction: a four-state pilot study from the Cooperative Cardiovascular Project. JAMA. 1995;273:1509–1514
  43. Cannon CP, Moliterno DJ, Every N, et al.  Implementation of AHCPR guidelines for unstable angina in 1996: unfortunate differences between men and women. Results from the multicenter GUARANTEE registry. J Am Coll Cardiol. 1997;29:217; [abstract]
  44. Scirica BM, Moliterno DJ, Every NR, et al.  Differences between men and women in the management of unstable angina pectoris: the GUARANTEE Registry. Am J Cardiol. 1999;84:1145–1150
  45. Cannon CP, Bahit MC, Haugland JM, et al. Underutilization of evidence-based medications in acute ST elevation myocardial infarction: results of the Thrombolysis In Myocardial Infarction (TIMI) 9 registry. Crit Path Cardiol. In press.
  46. Eagle K. The American College of Cardiology Guidelines Application in Practice (GAP) project: initial results. Orlando: The College; 2001; Proceedings of the annual meeting of the American College of Cardiology; 2201 Mar 19; 2001; Orlando, Fla
  47. Fonarow GC, Gawlinski A, Moughrabi S, et al.  Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). Am J Cardiol. 2001;87:819–822
  48. Every NR, Larson EB, Litwin PE, et al.  The association between on-site cardiac catheterization facilities and the use of coronary angiography after acute myocardial infarction. N Engl J Med. 1993;329:546–551
  49. Rouleau JL, Moye LA, Pfeffer MA, et al.  A comparison of management patterns after acute myocardial infarction in Canada and the United States. N Engl J Med. 1993;328:779–784
  50. Mark DB, Naylor CD, Hlatky MA, et al.  Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med. 1994;331:1130–1135
  51. Pilote L, Califf RM, Sapp S, et al.  Regional variation across the United States in the management of acute myocardial infarction. N Engl J Med. 1995;333:565–572
  52. Tu JV, Pashos CL, Naylor D, et al.  Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada. JAMA. 1997;336:1500–1505
  53. Every NR, Parson LS, Fihn SD, et al.  Long-term outcome in acute myocardial infarction patients admitted to hospitals with and without on-site cardiac catheterization facilities. Circulation. 1997;96:1770–1775
  54. TIMI Study Group . Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II trial. N Engl J Med. 1989;320:618–627
  55. Williams DO, Braunwald E, Knatterud G, et al.  One-year results of the Thrombolysis in Myocardial Infarction Investigation (TIMI) phase II trial. Circulation. 1992;85:533–542
  56. Terrin ML, Williams DO, Kleiman NS, et al.  Two- and three-year results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II clinical trial. J Am Coll Cardiol. 1993;22:1763–1772
  57. SWIFT Should We Intervene Following Thrombolysis? Trial Study Group . SWIFT trial of delayed elective intervention vs conservative treatment after thrombolysis with anistreplase in acute myocardial infarction. BMJ. 1991;302:555–560
  58. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Lancet. 1999;354:708–715
  59. Wallentin L, Lagerqvist B, Husted S, et al.  Outcome at 1 year after an invasive compared to a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomized trial. FRISC II investigators. Fast revascularisation during instability in coronary artery disease. Lancet. 2000;356:9–16
  60. Cannon CP, Weintraub WS, Demopoulos L, et al.  Results of the treat angina with aggrastat and determine the cost of therapy with an invasive or conservative strategy (TACTICS-TIMI 18) trial: a comparison of invasive versus conservative strategy in patients with unstable angina and non-ST-segment elevation myocardial infarction. Circulation. 2000;102:2627; [abstract]
  61. Multicenter Postinfarction Research Group . Risk stratification and survival after myocardial infarction. N Engl J Med. 1983;309:331–336
  62. Bolling SF, Walters J, Monaghan H, et al.  Case management, critical pathways, and patient outcome after coronary artery bypass. Circulation. 1995;92:1–47 [abstract]
  63. London MJ, Shroyer AL, Jernigan V, et al.  Fast-track cardiac surgery in a Department of Veterans Affairs patient population. Ann Thorac Surg. 1997;64:134–141
  64. Frohlich J, Karavite D, Erdum N, et al.  Implementation of ACC/AHA guidelines for preoperative cardiac risk assessment before aortic surgery: implications for resource utilization. J Am Coll Cardiol. 1997;29:392; [abstract]
  65. TIMI IIIB Investigators . Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI IIIB trial. Circulation. 1994;89:1545–1556
  66. Anderson HV, Cannon CP, Stone PH, et al.  One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial: a randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q-wave myocardial infarction. J Am Coll Cardiol. 1995;26:1643–1650
  67. Stone PH, Thompson B, Anderson HV, et al.  Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: the TIMI III Registry. JAMA. 1996;275:1104–1112
  68. Cannon CP, McCabe CH, Stone PH, et al.  The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III registry ECG ancillary study. J Am Coll Cardiol. 1997;30:133–140
  69. Newby LK, Califf RM, Guerci A, et al.  Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial. J Am Coll Cardiol. 1996;27:625–632
  70. Braunwald E. Unstable angina: a classification. Circulation. 1989;80:410–414
  71. Hillis LD, Forman S, Braunwald E, et al.  Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. J Am Coll Cardiol. 1990;16:313–315
  72. Hamm CW, Ravkilde J, Gerhardt W, et al.  The prognostic value of troponin T in unstable angina. N Engl J Med. 1992;327:146–150
  73. Antman EM, Tanasijevic MJ, Thompson B, et al.  Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996;335:1342–1349
  74. Ohman EM, Armstrong P, Christenson RH, et al.  Cardiac troponin T levels for risk stratification in unstable myocardial ischemia. N Engl J Med. 1996;335:1333–1341
  75. Mark DB, Sigmon K, Topol EJ, et al.  Identification of acute myocardial infarction patients suitable for early hospital discharge after aggressive interventional therapy: results from the Thrombolysis and Angioplasty in Acute Myocardial Infarction Registry. Circulation. 1991;83:1186–1193
  76. Topol EJ, Bure K, O'Neill WW, et al.  A randomized controlled trial of hospital discharge three days after myocardial infarction in the era of reperfusion. N Engl J Med. 1988;318:1083–1088
  77. Grines CL, Marsalese DL, Brodie B, et al.  Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. J Am Coll Cardiol. 1998;31:967–972
  78. Pozen MW, D'Agostino RB, Selker HP, et al.  A predictive instrument to improve coronary care unit admission practices in acute ischemic heart disease: a prospective multicenter clinical trial. N Engl J Med. 1984;310:1273–1278
  79. Goldman L, Cook EF, Brand DA, et al.  A computer protocol to predict myocardial infarction in emergency department patients with chest pain. N Engl J Med. 1988;318:797–803
  80. Goldman L, Cook EF, Johnson PA, et al.  Prediction of the need for intensive care in patients who come to the emergency room with acute chest pain. N Engl J Med. 1996;334:1498–1504
  81. Braunwald E, Antman EM, Beasley JW, et al.  ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). Circulation. 2000;102:1193–1209
  82. Gibler WB, Runyon JP, Levy RC, et al.  A rapid diagnostic and treatment center for patients with acute chest pain in the emergency department. Ann Emerg Med. 1995;25:1–8
  83. Gomez MA, Anderson JL, Karagounis LA, et al.  An emergency department-based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense: results of a randomized study (ROMIO). J Am Coll Cardiol. 1996;28:25–33
  84. Graff LG, Dallara J, Ross MA, et al.  Impact on the care of the emergency department chest pain patient from the Chest Pain Evaluation Registry (CHEPER) study. Am J Cardiol. 1997;80:563–568
  85. Roberts RR, Zalenski RJ, Mensah EK, et al.  Costs of an emergency department-based accelerated diagnostic protocol vs hospitalization in patients with chest pain: a randomized controlled trial. JAMA. 1997;278:1670–1676
  86. Zalenski RJ, McCarren M, Roberts R, et al.  An evaluation of a chest pain diagnostic protocol to exclude acute cardiac ischemia in the emergency department. Ann Intern Med. 1997;157:1085–1091
  87. Farkouh ME, Smars PA, Reeder GS, et al.  A clinical trial of a chest-pain observation unit for patients with unstable angina. N Engl J Med. 1998;339:1882–1888
  88. Chen J, Radford MJ, Wang Y, et al.  Do “America's Best Hospitals” perform better for acute myocardial infarction?. N Engl J Med. 1999;340:286–292
  89. Chu S, Cesnik B. Improving clinical pathway design: lessons learned from a computerized prototype. Int Med Inf. 1998;51:1–11
  90. Holmboe ES, Meehan TP, Radford MJ, et al.  Use of critical pathways to improve the care of patients with acute myocardial infarction. Am J Med. 1999;107:324–331
  91. In:  Eagle KA editors. Clinical decision manual. Philadelphia: Lippincott-Williams & Wilkins; 2000;p. 18–19
  92. Eagle KA, Moscucci M, Kline-Rogers E, et al.  Evaluating and improving the delivery of heart care: the University of Michigan experience. Am J Man Care. 1998;4:1300–1309
  93. Tatum JL, Jesse RL, Kontos MC, et al.  Comprehensive strategy for the evaluation and triage of the chest pain patient. Ann Emerg Med. 1997;29:116–125
  94. Topol EJ, Califf RM. Scorecard cardiovascular medicine. Its impact and future directions. Ann Intern Med. 1994;120:65–70
  95. Topol EJ, Block PC, Holmes DR, et al.  Readiness for the scorecard era in cardiovascular medicine. Am J Cardiol. 1995;75:1170–1173 [editorial]

☆ *A list of the writing group members appears in the Appendix.

☆☆ Mary M. Hand, MSPH, RN, Office of Prevention, Education, and Control, National Heart, Lung, and Blood Institute, National Institutes of Health, 31 Center Dr, MSC 2480, Bethesda, MD 20892.

★ E-mail: handm@nhlbi.nih.gov

PII: S0002-8703(02)18784-9

doi: 10.1067/mhj.2002.120260

American Heart Journal
Volume 143, Issue 5 , Pages 777-789 , May 2002

Article Tools

* Image Usage & Resolution